Loading...

Evergrande Health Industry Group

SEHK:708
Snowflake Description

Imperfect balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
708
SEHK
HK$70B
Market Cap
  1. Home
  2. HK
  3. Healthcare
Company description

Evergrande Health Industry Group Limited, an investment holding company, operates as a health management company in the People’s Republic of China. The last earnings update was 53 days ago. More info.


Add to Portfolio Compare Print
  • Evergrande Health Industry Group has significant price volatility in the past 3 months.
708 Share Price and Events
7 Day Returns
-12.4%
SEHK:708
-2.1%
HK Healthcare
-1.3%
HK Market
1 Year Returns
92.2%
SEHK:708
-25.7%
HK Healthcare
-15.9%
HK Market
708 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Evergrande Health Industry Group (708) -12.4% -9.2% -30.1% 92.2% 679.8% 29937%
HK Healthcare -2.1% -6.5% -17.5% -25.7% -27.5% -8%
HK Market -1.3% -2.7% -10.1% -15.9% 19.1% 4.6%
1 Year Return vs Industry and Market
  • 708 outperformed the Healthcare industry which returned -25.7% over the past year.
  • 708 outperformed the Market in Hong Kong which returned -15.9% over the past year.
Price Volatility
708
Industry
5yr Volatility vs Market
Related Companies

Sorry, no analysis for Evergrande Health Industry Group's competitors could be found in our database.

Value

 Is Evergrande Health Industry Group undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.

In this section, we usually try to help investors determine whether Evergrande Health Industry Group is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Evergrande Health Industry Group has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.

Show me the analysis anyway

INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Evergrande Health Industry Group. This is due to cash flow or dividend data being unavailable. The share price is HK$8.11.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Evergrande Health Industry Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Evergrande Health Industry Group's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
SEHK:708 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in CNY CN¥-0.17
SEHK:708 Share Price ** SEHK (2019-06-17) in HKD HK$8.11
SEHK:708 Share Price converted to CNY reporting currency Exchange rate (HKD/ CNY) 0.884 CN¥7.17
Hong Kong Healthcare Industry PE Ratio Median Figure of 19 Publicly-Listed Healthcare Companies 15.12x
Hong Kong Market PE Ratio Median Figure of 1,487 Publicly-Listed Companies 10.68x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Evergrande Health Industry Group.

SEHK:708 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= SEHK:708 Share Price ÷ EPS (both in CNY)

= 7.17 ÷ -0.17

-43.34x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Evergrande Health Industry Group is loss making, we can't compare its value to the HK Healthcare industry average.
  • Evergrande Health Industry Group is loss making, we can't compare the value of its earnings to the Hong Kong market.
Price based on expected Growth
Does Evergrande Health Industry Group's expected growth come at a high price?
Raw Data
SEHK:708 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -43.34x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Hong Kong Healthcare Industry PEG Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 1.03x
Hong Kong Market PEG Ratio Median Figure of 466 Publicly-Listed Companies 0.75x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Evergrande Health Industry Group, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Evergrande Health Industry Group's assets?
Raw Data
SEHK:708 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in CNY CN¥-0.08
SEHK:708 Share Price * SEHK (2019-06-17) in HKD HK$8.11
SEHK:708 Share Price converted to CNY reporting currency Exchange rate (HKD/ CNY) 0.884 CN¥7.17
Hong Kong Healthcare Industry PB Ratio Median Figure of 35 Publicly-Listed Healthcare Companies 1.68x
Hong Kong Market PB Ratio Median Figure of 2,169 Publicly-Listed Companies 0.93x
SEHK:708 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= SEHK:708 Share Price ÷ Book Value per Share (both in CNY)

= 7.17 ÷ -0.08

-93.52x

* Primary Listing of Evergrande Health Industry Group.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Evergrande Health Industry Group has negative assets, we can't compare the value of its assets to the HK Healthcare industry average.

Next steps:

  1. Take a look at our analysis of 708’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Evergrande Health Industry Group's regulatory filings and announcements.
  3. Show me more potentially undervalued companies in the Healthcare industry
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Value checks
We assess Evergrande Health Industry Group's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Evergrande Health Industry Group has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Evergrande Health Industry Group expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Evergrande Health Industry Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
15.3%
Expected Healthcare industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Evergrande Health Industry Group expected to grow at an attractive rate?
  • Unable to compare Evergrande Health Industry Group's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Evergrande Health Industry Group's earnings growth to the Hong Kong market average as no estimate data is available.
  • Unable to compare Evergrande Health Industry Group's revenue growth to the Hong Kong market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
SEHK:708 Future Growth Rates Data Sources
Data Point Source Value (per year)
Hong Kong Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 15.3%
Hong Kong Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 12.7%
Hong Kong Market Earnings Growth Rate Market Cap Weighted Average 11%
Hong Kong Market Revenue Growth Rate Market Cap Weighted Average 10.7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
SEHK:708 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CNY Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
SEHK:708 Future Estimates Data
Date (Data in CNY Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
SEHK:708 Past Financials Data
Date (Data in CNY Millions) Revenue Cash Flow Net Income *
2018-12-31 3,133 -3,938 -1,429
2018-09-30 2,598 -3,741 -494
2018-06-30 2,063 -3,545 441
2018-03-31 1,696 -2,733 377
2017-12-31 1,328 -1,921 313
2017-06-30 462 965 104
2017-03-31 336 352 74
2016-12-31 214 -268 44
2016-06-30 355 -440 -33
2016-03-31 349 -210 12

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Evergrande Health Industry Group is high growth as no earnings estimate data is available.
  • Unable to determine if Evergrande Health Industry Group is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
SEHK:708 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Evergrande Health Industry Group Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SEHK:708 Future Estimates Data
Date (Data in CNY Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
SEHK:708 Past Financials Data
Date (Data in CNY Millions) EPS *
2018-12-31 -0.17
2018-09-30 -0.06
2018-06-30 0.05
2018-03-31 0.04
2017-12-31 0.04
2017-06-30 0.01
2017-03-31 0.01
2016-12-31 0.01
2016-06-30 0.00
2016-03-31 0.00

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Evergrande Health Industry Group will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of 708’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. Evergrande Health Industry Group's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. Evergrande Health Industry Group's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Evergrande Health Industry Group's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Hong Kong market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Hong Kong market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Evergrande Health Industry Group has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Evergrande Health Industry Group performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Evergrande Health Industry Group's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Evergrande Health Industry Group does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Evergrande Health Industry Group's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Evergrande Health Industry Group's 1-year growth to the HK Healthcare industry average as it is not currently profitable.
Earnings and Revenue History
Evergrande Health Industry Group's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Evergrande Health Industry Group Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SEHK:708 Past Revenue, Cash Flow and Net Income Data
Date (Data in CNY Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 3,133.02 -1,429.38 600.88
2018-09-30 2,597.79 -493.94 440.38
2018-06-30 2,062.56 441.50 279.89
2018-03-31 1,695.52 377.01 242.25
2017-12-31 1,328.47 312.53 204.62
2017-06-30 462.31 103.69 45.30
2017-03-31 336.32 73.61 47.02
2016-12-31 213.53 43.74 50.33
2016-06-30 355.04 -32.67 145.92
2016-03-31 349.43 11.84 144.98
2015-12-31 356.46 55.78 149.25
2015-06-30 332.57 95.68 137.18
2015-03-31 334.45 46.52 126.53
2014-12-31 336.50 -2.62 115.94
2014-09-30 346.38 3.06 114.56
2014-06-30 365.57 8.84 116.25
2014-03-31 374.69 12.01 114.84
2013-12-31 374.32 14.80 110.64
2013-09-30 384.64 16.27 110.01
2013-06-30 392.16 17.64 108.53
2013-03-31 399.76 18.62 108.46
2012-12-31 404.78 19.50 107.66
2012-09-30 408.73 21.85 107.38
2012-06-30 413.70 24.30 107.34

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Evergrande Health Industry Group has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
  • It is difficult to establish if Evergrande Health Industry Group has efficiently used its assets last year compared to the HK Healthcare industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Evergrande Health Industry Group improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Evergrande Health Industry Group's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Evergrande Health Industry Group has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Evergrande Health Industry Group's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Evergrande Health Industry Group's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Evergrande Health Industry Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Evergrande Health Industry Group's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Evergrande Health Industry Group's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Evergrande Health Industry Group has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Evergrande Health Industry Group Company Filings, last reported 5 months ago.

SEHK:708 Past Debt and Equity Data
Date (Data in CNY Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 -662.47 15,322.36 1,570.01
2018-09-30 -662.47 15,322.36 1,570.01
2018-06-30 1,030.46 4,993.12 823.25
2018-03-31 1,030.46 4,993.12 823.25
2017-12-31 832.24 5,355.28 2,301.68
2017-06-30 660.68 2,552.71 1,853.90
2017-03-31 674.01 2,604.22 1,891.30
2016-12-31 566.85 1,600.95 1,042.39
2016-06-30 537.10 728.15 129.13
2016-03-31 521.60 707.13 125.40
2015-12-31 485.73 153.49 376.66
2015-06-30 466.55 59.99 531.63
2015-03-31 466.44 59.97 531.50
2014-12-31 366.24 0.00 74.50
2014-09-30 361.98 0.00 73.64
2014-06-30 365.92 0.00 72.94
2014-03-31 365.50 0.00 72.85
2013-12-31 362.65 0.00 68.66
2013-09-30 366.61 0.00 69.41
2013-06-30 356.88 0.00 52.93
2013-03-31 360.84 0.00 53.52
2012-12-31 363.50 40.71 82.72
2012-09-30 366.50 41.05 83.40
2012-06-30 356.35 43.81 91.31
  • Evergrande Health Industry Group has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
  • Irrelevant to check if Evergrande Health Industry Group's debt level has increased considering it has negative shareholder equity.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Information is not available.
  • Unable to confirm if Evergrande Health Industry Group has at least 1 year of cash runway based on growing free cash flows without relevant data.
X
Financial health checks
We assess Evergrande Health Industry Group's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Evergrande Health Industry Group has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Evergrande Health Industry Group's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Evergrande Health Industry Group dividends.
If you bought HK$2,000 of Evergrande Health Industry Group shares you are expected to receive HK$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Evergrande Health Industry Group's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Evergrande Health Industry Group's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
SEHK:708 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Hong Kong Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 13 Stocks 2.5%
Hong Kong Market Average Dividend Yield Market Cap Weighted Average of 966 Stocks 3.7%
Hong Kong Minimum Threshold Dividend Yield 10th Percentile 1.2%
Hong Kong Bottom 25% Dividend Yield 25th Percentile 2.1%
Hong Kong Top 25% Dividend Yield 75th Percentile 6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

SEHK:708 Future Dividends Estimate Data
Date (Data in CN¥) Dividend per Share (annual) Avg. No. Analysts
SEHK:708 Past Annualized Dividends Data
Date (Data in CN¥) Dividend per share (annual) Avg. Yield (%)
2016-09-26 0.000 0.000
2016-08-18 0.000 0.000
2016-04-28 0.000 0.000
2016-03-23 0.000 0.000
2015-09-29 0.000 0.000
2015-03-04 0.000 0.000
2015-02-16 0.000 0.000
2014-10-03 0.000 0.555
2014-09-18 0.000 1.237
2013-10-09 0.001 2.872
2013-09-24 0.001 2.891
2013-02-22 0.001 2.460
2012-10-11 0.001 2.914
2012-09-26 0.001 3.354
2012-02-23 0.001 4.677
2011-09-30 0.002 5.594
2011-02-24 0.002 3.976
2010-10-12 0.002 3.035
2010-02-25 0.002 3.738
2009-09-29 0.002 6.033

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Evergrande Health Industry Group has not reported any payouts.
  • Unable to verify if Evergrande Health Industry Group's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Evergrande Health Industry Group's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Evergrande Health Industry Group has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Evergrande Health Industry Group's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Evergrande Health Industry Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Evergrande Health Industry Group has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Evergrande Health Industry Group's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Siquan Li
COMPENSATION CN¥4,676,851
AGE 33
TENURE AS CEO 0.9 years
CEO Bio

Mr. Siquan Li is the Chief Executive Officer Health Industry Group Limited since July 20, 2018 and also served as it's executive Director since July 20, 2018 Until February 1,2019. He tapped into the real estate industry and has over 12 years of experience in various areas such as investment, development and marketing. He graduated from Hohai University with a bachelor’s degree in engineering management and studied at the department of construction management, Tsinghua University for a master’s degree in project management. Prior to joining the Company, Mr. Li was the general manager of China Evergrande Group Hainan Company and the vice president of Evergrande Ocean Flower Island Industry Group. In 2017, he was appointed as the executive vice president of Evergrande Tourism Group and the chairman of Suzhou Evergrande Fairyland Company.

CEO Compensation
  • Insufficient data for Siquan to compare compensation growth.
  • Siquan's remuneration is about average for companies of similar size in Hong Kong.
Management Team Tenure

Average tenure and age of the Evergrande Health Industry Group management team in years:

0.9
Average Tenure
45
Average Age
  • The average tenure for the Evergrande Health Industry Group management team is less than 2 years, this suggests a new team.
Management Team

Shouming Shi

TITLE
Chairman
COMPENSATION
CN¥115K
AGE
44
TENURE
1.1 yrs

Siquan Li

TITLE
Chief Executive Officer
COMPENSATION
CN¥5M
AGE
33
TENURE
0.9 yrs

Jianjun Peng

TITLE
Vice Chairman
COMPENSATION
CN¥69K
AGE
48
TENURE
0.8 yrs

Liyong Qin

TITLE
Executive Director
AGE
40
TENURE
0.3 yrs

Darong Pan

TITLE
Chief Financial Officer
AGE
45

Dawn Pun

TITLE
Chief Editor of Weekend Weekly
AGE
44

Suet Chung Tso

TITLE
Publisher and Chief Editor of Oriental Sunday
AGE
48

Mag Leung

TITLE
Chief Editor of Fashion & Beauty
AGE
45
TENURE
14.3 yrs

Chi Ming Cheung

TITLE
Chief Editor of New Monday and Publisher of Fashion & Beauty
AGE
47

Thomas Lui

TITLE
Chief Editor of Economic Digest
AGE
51
Board of Directors Tenure

Average tenure and age of the Evergrande Health Industry Group board of directors in years:

2.7
Average Tenure
46
Average Age
  • The average tenure for the Evergrande Health Industry Group board of directors is less than 3 years, this suggests a new board.
Board of Directors

Shouming Shi

TITLE
Chairman
COMPENSATION
CN¥115K
AGE
44
TENURE
1.1 yrs

Jianjun Peng

TITLE
Vice Chairman
COMPENSATION
CN¥69K
AGE
48
TENURE
0.8 yrs

Liyong Qin

TITLE
Executive Director
AGE
40
TENURE
0.3 yrs

David Chau

TITLE
Independent Non-Executive Director
COMPENSATION
CN¥300K
AGE
54
TENURE
4.3 yrs

Jianwen Guo

TITLE
Independent Non-Executive Director
COMPENSATION
CN¥300K
AGE
42
TENURE
4.3 yrs

Wu Xie

TITLE
Independent Non-Executive Director
COMPENSATION
CN¥300K
AGE
53
TENURE
4.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (HK$) Value (HK$)
X
Management checks
We assess Evergrande Health Industry Group's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Evergrande Health Industry Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Why You Should Like Evergrande Health Industry Group Limited’s (HKG:708) ROCE

Specifically, we're going to calculate its Return On Capital Employed (ROCE), in the hopes of getting some insight into the business. … Understanding Return On Capital Employed (ROCE). … ROCE measures the amount of pre-tax profits a company can generate from the capital employed in its business.

Simply Wall St -

Should We Be Delighted With Evergrande Health Industry Group Limited's (HKG:708) ROE Of 43%?

To keep the lesson grounded in practicality, we'll use ROE to better understand Evergrande Health Industry Group Limited (HKG:708). … Evergrande Health Industry Group has a ROE of 43%, based on the last twelve months. … Check out our latest analysis for Evergrande Health Industry Group?

Simply Wall St -

Evergrande Health Industry Group Limited (HKG:708) Earns A Nice Return On Capital Employed

To be precise, we'll consider its Return On Capital Employed (ROCE), as that will inform our view of the quality of the business. … Return On Capital Employed (ROCE): What is it? … ROCE measures the amount of pre-tax profits a company can generate from the capital employed in its business.

Simply Wall St -

Is Evergrande Health Industry Group Limited's (HKG:708) 43% Better Than Average?

We'll use ROE to examine Evergrande Health Industry Group Limited (HKG:708), by way of a worked example. … Over the last twelve months Evergrande Health Industry Group has recorded a ROE of 43%. … See our latest analysis for Evergrande Health Industry Group?

Simply Wall St -

What Should You Know About Evergrande Health Industry Group Limited's (HKG:708) Return On Capital?

and want to begin learning the link between Evergrande Health Industry Group Limited (HKG:708)’s return fundamentals and stock market performance. … Purchasing Evergrande Health Industry Group gives you an ownership stake in the company. … Thus, to understand how your money can grow by investing in Evergrande Health Industry Group, you need to look at what the company returns to owners for the use of their capital, which can be done in many ways but today we will use return on capital employed (ROCE)

Simply Wall St -

Evergrande Health Industry Group Limited (HKG:708) Delivered A Better ROE Than The Industry, Here’s Why

and want to better understand how you can grow your money by investing in Evergrande Health Industry Group Limited (HKG:708). … Evergrande Health Industry Group Limited (HKG:708) delivered an ROE of 36.64% over the past 12 months, which is an impressive feat relative to its industry average of 8.18% during the same period. … Sustainability can be gauged by a company’s financial leverage – the more debt it has, the higher ROE is pumped up in the short term, at the expense of long term interest payment burden

Simply Wall St -

Is Evergrande Health Industry Group Limited's (HKG:708) 36.64% ROE Strong Compared To Its Industry?

View our latest analysis for Evergrande Health Industry Group Breaking down ROE — the mother of all ratios Return on Equity (ROE) is a measure of Evergrande Health Industry Group’s profit relative to its shareholders’ equity. … Return on Equity = Net Profit ÷ Shareholders Equity ROE is measured against cost of equity in order to determine the efficiency of Evergrande Health Industry Group’s equity capital deployed. … Evergrande Health Industry Group’s ROE is impressive relative to the industry average and also covers its cost of equity.

Simply Wall St -

How Financially Strong Is Evergrande Health Industry Group Limited (HKG:708)?

Small-caps and large-caps are wildly popular among investors, however, mid-cap stocks, such as Evergrande Health Industry Group Limited (SEHK:708), with a market capitalization of HK$27.30B, rarely draw their attention from the investing community. … View our latest analysis for Evergrande Health Industry Group Does 708 generate an acceptable amount of cash through operations? … I recommend you continue to research Evergrande Health Industry Group to get a more holistic view of the stock by looking at: Historical Performance: What has 708's returns been like over the past?

Simply Wall St -

Who Owns Most Of Evergrande Health Industry Group Limited (HKG:708)?

In this article, I'm going to take a look at Evergrande Health Industry Group Limited’s (SEHK:708) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors. … SEHK:708 Insider_trading Feb 20th 18 General Public Ownership The general public holds a substantial 24.92% stake in 708, making it a highly popular stock among retail investors. … Thus, investors should dig deeper into 708's business relations with these companies and how it can affect shareholder returns in the long-term.Next Steps: With a low level of institutional ownership, investors in 708 need not worry about non-fundamental factors such as ownership structure causing large impact on stock prices.

Simply Wall St -

What You Must Know About Evergrande Health Industry Group Limited's (HKG:708) Risks

If you are looking to invest in Evergrande Health Industry Group Limited’s (SEHK:708), or currently own the stock, then you need to understand its beta in order to understand how it can affect the risk of your portfolio. … Check out our latest analysis for Evergrande Health Industry Group An interpretation of 708's beta Evergrande Health Industry Group’s five-year beta of 2.47 means that the company’s value will swing up by more than the market during prosperous times, but also drop down by more in times of downturns. … However, this is the opposite to what 708’s actual beta value suggests, which is higher stock volatility relative to the market.

Simply Wall St -

Company Info

Description

Evergrande Health Industry Group Limited, an investment holding company, operates as a health management company in the People’s Republic of China. It develops and sells health and living properties; and provides community health management, medical cosmetology, and anti-aging services, as well as elderly care and rehabilitation. The company is involved in the wholesale of home care and healthcare products; and cosmetic products, as well as provision of healthcare services, hospital management, and software and advertisement design services. In addition, it offers information technology consultancy services. The company engages in the real estate development and operations; research and development of pharmaceuticals; and production of medical equipment. Further, it is involved in the research, development, production, and sales of new energy vehicles. The company was formerly known as New Media Group Holdings Limited and changed its name to Evergrande Health Industry Group Limited in April 2015. Evergrande Health Industry Group Limited was founded in 1999 and is headquartered in Guangzhou, China. Evergrande Health Industry Group Limited is a subsidiary of China Evergrande Group.

Details
Name: Evergrande Health Industry Group Limited
708
Exchange: SEHK
Founded: 1999
HK$70,070,400,000
8,640,000,000
Website: http://www.evergrandehealth.com
Address: Evergrande Health Industry Group Limited
Evergrande International Center,
28th Floor,
Guangzhou,
Guangdong Province, 510620,
China
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
SEHK 708 Ordinary Shares The Stock Exchange of Hong Kong Ltd. HK HKD 12. Feb 2008
DB 4NM1 Ordinary Shares Deutsche Boerse AG DE EUR 12. Feb 2008
TSEC 910708 TDR EACH REPR 50 SHS Taiwan Stock Exchange TW TWD 19. Jul 2011
Number of employees
Current staff
Staff numbers
1,478
Evergrande Health Industry Group employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/18 12:42
End of day share price update: 2019/06/17 00:00
Last estimates confirmation: 2017/04/28
Last earnings filing: 2019/04/26
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.